Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Toxics|September 23, 2020
Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and PrognosisVanessa M López-Ozuna, Ishita Gupta, Ryan Liu Chen Kiow, et al.
Gynecologic Oncology|July 28, 2019
Risk factors for lymph nodes involvement in obese women with endometrial carcinomasMichel Wissing, Cristina Mitric, Zainab Amajoud, et al.
Frontiers in Oncology|July 26, 2021
Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial CancerVanessa M López-Ozuna, Liron Kogan, Mahmood Y Hachim, et al.
Frontiers in Oncology|November 15, 2021
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum AgentsEmad Matanes, Vanessa M López-Ozuna, David Octeau, et al.
Molecular Cancer Therapeutics|October 17, 2014
Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancerBella S Guerrouahen, Jennifer Pasquier, Nadine Abu Kaoud, et al.
Gynecologic Oncology Reports|December 24, 2019
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsyDavid Octeau, Jeremie Abitbol, Zainab Amajoud, et al.
Molecular Cancer Research : MCR|September 19, 2019
Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant ChemotherapyDavid Octeau, Roy Kessous, Kathleen Klein, et al.
NAR Cancer|April 11, 2022
Multi-omics data integration analysis identifies the spliceosome as a key regulator of DNA double-strand break repairDana Sherill-Rofe, Oded Raban, Steven Findlay, et al.
Gynecologic Oncology|November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysisCécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Frontiers in Oncology|May 1, 2023
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancerAlba Galan, Arturo Papaluca, Ali Nejatie, et al.
Pageof 8